Probiodrug signs agreement with Rentschler for manufacture of its pGlu-Abeta targeting antibody PBD-C06

Probiodrug to attend and present at US Life Science Conferences
Probiodrug collaborates with the Paul-Flechsig-Institute for Brain Research, Leipzig University, Germany